Papilledema vs Pseudopapilledema
Last updated: October 2026
Key points in 60 seconds
- Papilloedema is disc swelling from raised intracranial pressure and is almost always bilateral.
- Pseudopapilloedema is most often optic disc drusen; also small crowded or tilted discs.
- OCT is the main tool: smooth contour and thick RNFL in papilloedema; lumpy contour and normal RNFL with drusen.
- Autofluorescence and B-scan show buried drusen; FFA shows late leakage in true papilloedema.
- True papilloedema needs urgent imaging with venography to exclude a mass or venous sinus thrombosis.
Distinguishing true papilledema from pseudopapilledema matters enormously — misdiagnosing pseudopapilledema as papilledema leads to unnecessary lumbar punctures and neuroimaging; missing true papilledema risks missing a mass lesion, venous sinus thrombosis, or idiopathic intracranial hypertension. OCT has become central to making this distinction reliably.
Definitions
- Papilledema — optic disc swelling specifically due to raised intracranial pressure; the retinal nerve fiber layer itself is edematous
- Pseudopapilledema — anomalous elevation of the optic disc without true nerve fiber layer edema; most commonly caused by optic disc drusen, but also small crowded discs, tilted discs, and other congenital anomalies
Clinical clues favoring true papilledema
- Bilateral (true papilledema from raised ICP is almost always bilateral; pseudopapilledema can be unilateral or bilateral)
- Peripapillary hemorrhages, cotton wool spots, and choroidal folds are strong supporting signs when present
- Obscured disc margins with a blurred, indistinct vessel pattern crossing the disc edge
- Associated symptoms: headache, transient visual obscurations, pulsatile tinnitus, diplopia (especially CN VI palsy from raised ICP)
OCT: the current primary distinguishing tool
| OCT finding | Papilledema | Pseudopapilledema (ODD) |
|---|---|---|
| Internal disc contour | Smooth | "Lumpy-bumpy" irregular contour |
| Peripapillary RNFL thickness | Thickened, typically all quadrants (nasal quadrant has highest diagnostic value) | Normal or thin |
| Macular ganglion cell-inner plexiform layer | Normal early; thins later if chronic | Can be thinned if drusen compress axons directly |
| Hyperreflective subretinal material | Absent | May show hyperreflective bands/lumps corresponding to buried drusen |
SD-OCT has shown higher sensitivity than B-scan ultrasonography in several recent comparative series, though the two remain complementary in practice — ultrasound is excellent at directly visualizing calcified drusen (hyperechoic with shadowing) and can also assess optic nerve sheath diameter (a diameter >3.3mm supports raised ICP), while OCT gives detailed structural quantification of the nerve fiber layer itself.
Other supporting tools
- Fundus autofluorescence — buried optic disc drusen are autofluorescent and light up well before they become visible clinically, making this a fast, non-invasive screening step
- Fluorescein angiography — true papilledema shows early diffuse disc hyperfluorescence with late leakage (from blood-retina barrier breakdown); this leakage pattern is absent in pseudopapilledema
- OCT angiography (OCTA) — an active area of research; papilledema tends to show higher peripapillary flux index and perfusion, particularly nasally, though diagnostic accuracy is currently only moderate as an adjunct rather than a standalone test
A practical caveat
Optic disc drusen do not exclude a patient from also developing true papilledema later — a patient with known ODD who develops new peripapillary hemorrhages or subjective symptoms still deserves reassessment, not automatic reassurance based on their prior drusen diagnosis. Conditions like Chiari malformation can coexist with ODD, and distinguishing genuine ICP elevation from baseline drusen-related disc elevation in that setting specifically warrants multimodal imaging (OCT + autofluorescence + ultrasound) rather than clinical impression alone.
2026 update: when it is papilloedema from IIH
| Topic | What to know |
|---|---|
| Grading | Modified Frisén scale (0–5): see gradings page |
| IIHTT (2014) | In mild visual loss, acetazolamide (up to 4 g/day) plus weight loss improved fields, papilloedema and quality of life more than diet alone |
| Weight loss | The only disease-modifying treatment: IIH:WT showed bariatric surgery beats a community weight programme; GLP-1 receptor agonists are being studied and used for weight loss |
| Fulminant IIH | Rapid visual loss: urgent CSF diversion (shunt), optic nerve sheath fenestration or venous sinus stenting |
| Venous sinus stenting | Effective in observational series for patients with transverse sinus stenosis; randomised trials are under way |
| Always exclude | Venous sinus thrombosis (MR venography), drugs (tetracyclines, vitamin A, retinoids) and sleep apnoea |
Sources for this update: NORDIC IIH Study Group. Effect of acetazolamide on visual function in IIH (IIHTT). JAMA. 2014;311:1641-1651 | Mollan SP, et al. Effectiveness of bariatric surgery vs community weight management in IIH (IIH:WT). JAMA Neurol. 2021;78:678-686.
Revise with flip cards
Key references: Pseudopapilledema, EyeWiki (2025). | Validity of OCTA in the differential diagnosis of papilledema and pseudopapilledema. 2025. | A field guide to optic disc drusen. Modern Retina. 2026.
📘 Want the exam-ready deep dive? This topic, and much more is covered in Ophthalmology Explorer (A High-Yield Clinical Reference for Ophthalmology Residents, Fellows & Board Exams) — available on Kindle. See all my books.
Want to know more about treatment? Read about Neuro-Ophthalmology at Sadbhaav or book a consultation with Dr. Dhaval Patel.